Compare Ford Motor Company (F) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ford Motor Company vs GeneDx Holdings Corp — how do they compare? Ford Motor Company trades at $12.17 (market cap $48.85B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Ford Motor Company is far larger — about 24.2× GeneDx Holdings Corp's market cap, and Ford Motor Company pays a 4.9% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 105 Days and GeneDx Holdings Corp for 19 Days on average.
| F | WGS | |
|---|---|---|
Market Cap | $48.85B | $2.02B |
Volume | 57,748,965 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $167.51 |
52-Week Low | $11.21 | $34.51 |
Typical Hold Time | 105 Days | 19 Days |
Enterprise Value | $180.81B | $2.05B |
Dividend Yield | 4.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.25, up 1.03% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported a net loss of $8.18 billion in 2025 despite $187.27 billion revenue, with negative profit margins and declining sales trends. Recent news highlights supplier disruptions affecting F-150 production and a 6.6% Q3 sales decline, though the company maintains its No. 3 U.S. sales position.
Ford faces significant challenges with negative profitability and competitive pressures, though analyst consensus targets $15.75 suggesting 28% upside. The stock offers value with low P/S ratio (0.26) and dividend yield, but investors must weigh execution risks against turnaround potential in the evolving automotive landscape.
GeneDx (WGS) trades at $67.73, down 1.17% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations, and returned to adjusted profitability early. However, 2026 fundamentals show concerning trends with a net loss of $106 million and negative profit margins. Recent news highlights product innovations and leadership recognition, while technical analysis indicates the stock is trading near key support at $66.
The investment outlook presents a dichotomy between strong analyst conviction (90.9% buy ratings, $81 consensus target) and challenging fundamentals. While operational improvements and genomic testing growth offer potential upside, persistent losses and negative cash flow trends create significant execution risk. The stock's current position near support levels combined with oversold RSI readings suggests potential for near-term bounce, but sustainable gains require meaningful profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
